Chemoinformaics analysis of 3-O-TRANS-P-COUMAROYL-ROTUNDIC-ACID
| Molecular Weight | 632.838 | nRot | 5 |
| Heavy Atom Molecular Weight | 580.422 | nRig | 36 |
| Exact Molecular Weight | 632.371 | nRing | 6 |
| Solubility: LogS | -4.063 | nHRing | 0 |
| Solubility: LogP | 5.318 | No. of Aliphatic Rings | 5 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 98 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 46 | No. of Aromatic Carbocycles | 1 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 39 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 6 |
| nHA | 6 | APOL | 105.417 |
| nHD | 4 | BPOL | 55.6388 |
| QED | 0.158 |
| Synth | 5.339 |
| Natural Product Likeliness | 2.972 |
| NR-PPAR-gamma | 0.972 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.005 |
| HIA | 0.106 |
| CACO-2 | -5.52 |
| MDCK | 0.0000168 |
| BBB | 0.449 |
| PPB | 0.992669 |
| VDSS | 0.48 |
| FU | 0.0134313 |
| CYP1A2-inh | 0.01 |
| CYP1A2-sub | 0.376 |
| CYP2c19-inh | 0.023 |
| CYP2c19-sub | 0.684 |
| CYP2c9-inh | 0.126 |
| CYP2c9-sub | 0.472 |
| CYP2d6-inh | 0.029 |
| CYP2d6-sub | 0.185 |
| CYP3a4-inh | 0.286 |
| CYP3a4-sub | 0.332 |
| CL | 4.312 |
| T12 | 0.052 |
| hERG | 0.008 |
| Ames | 0.015 |
| ROA | 0.417 |
| SkinSen | 0.015 |
| Carcinogencity | 0.143 |
| EI | 0.01 |
| Respiratory | 0.907 |
| NR-Aromatase | 0.911 |
| Antiviral | Yes |
| Prediction | 0.870245 |